Revert the SIRT: Normalizing SIRT1 Activity in Myelodysplastic Stem Cells
- PMID: 30193128
- DOI: 10.1016/j.stem.2018.08.003
Revert the SIRT: Normalizing SIRT1 Activity in Myelodysplastic Stem Cells
Abstract
Myelodysplastic syndromes are hematologic malignancies with few treatment options and a propensity to transform to acute myeloid leukemia. In this issue of Cell Stem Cell, Sun et al. (2018) report that low SIRT1 levels in myelodysplastic stem cells contribute to aberrant self-renewal through enabling hyperacetylation and reduced activity of TET2.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment on
-
SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.Cell Stem Cell. 2018 Sep 6;23(3):355-369.e9. doi: 10.1016/j.stem.2018.07.018. Epub 2018 Aug 23. Cell Stem Cell. 2018. PMID: 30146412 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
